Literature DB >> 1013934

Bronchial carcinoma in patients with pre-existing unilateral lung disease.

T Yoneyama, T Naruke, K Suemasu, S Ishikawa.   

Abstract

Forty-six cases of primary bronchogenic carcinoma occurring in patients with other unilateral pleuropulmonary diseases were studied. In 37 cases (80-4%) carcinoma developed in the previously healthy lung. All but one squamous-cell carcinoma and all of five undifferentiated small-cell carcinomas developed in the previously healthy lung while 7 of 15 adenocarcinomas were in the lung with impaired ventilation. It is suggested that the bronchial epithelium of the healthy lung is more exposed to exogenous carcinogens than that of the diseased, underventilated lung, resulting in a higher risk of development of squamous-cell and undifferentiated small-cell carcinoma.

Entities:  

Mesh:

Year:  1976        PMID: 1013934      PMCID: PMC470489          DOI: 10.1136/thx.31.6.650

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  4 in total

1.  TEN-YEAR SURVIVAL IN LUNG CANCER. A STUDY OF 56 CASES.

Authors:  W L WATSON
Journal:  Cancer       Date:  1965-02       Impact factor: 6.860

2.  Bronchogenic carcinoma and pulmonary tuberculosis; problems in diagnosis with special reference to antituberculous chemotherapy.

Authors:  H WEISSMAN
Journal:  Am Rev Tuberc       Date:  1956-06

3.  Long term survivors after resection of bronchial carcinoma.

Authors:  T W Shields; C D Robinette
Journal:  Surg Gynecol Obstet       Date:  1973-05

4.  Long-term clinical follow-up after operation for lung carcinoma.

Authors:  R A Smith
Journal:  Thorax       Date:  1970-01       Impact factor: 9.139

  4 in total
  2 in total

Review 1.  Lung cancer coexisting with bullae.

Authors:  R Koike; M Sasaki; K Kuroda
Journal:  Jpn J Surg       Date:  1989-07

2.  Carcinoma of the lung and coexistent active pulmonary tuberculosis: diverse morphologic and radiographic presentations.

Authors:  L G Phillips; J Cunningham; N M Hillman; J Lewis
Journal:  J Natl Med Assoc       Date:  1984-02       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.